Post by icemandios on Apr 28, 2021 22:54:58 GMT
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of Elly Ryu as Principal Accounting Officer
Effective on April 22, 2021, Sesen Bio, Inc. (the “Company”) appointed Elly Ryu as the Company’s Corporate Controller and Principal Accounting Officer. No new compensatory arrangements will be entered into with Ms. Ryu in connection with her appointment as the Company’s Corporate Controller and Principal Accounting Officer.
Ms. Ryu, age 40, has served as the Company’s Senior Director, Accounting since February 2021. Before joining the Company, Ms. Ryu served as the Corporate Controller of Fi Holdings, LLC from January 2020 to February 2021. Previously, Ms. Ryu served as the Director of Accounting and Finance at Acrotech Biopharma, LLC from March 2019 to November 2019. Prior to that, Ms. Ryu served as the Director of Accounting and Finance at Spectrum Pharmaceuticals, Inc. from July 2017 to March 2019, Commercial Controller from January 2014 to June 2017, Assistant Controller from July 2010 to January 2014, and Senior Manager, Accounting and Finance from September 2009 to June 2010. Ms. Ryu holds a Masters in Business Administration from University of California, Irvine and a B.S. in Economics and Business Administration from the Sogang University, Seoul, South Korea.
There are no arrangements or understandings between Ms. Ryu and any other persons pursuant to which Ms. Ryu was appointed as the Corporate Controller and Principal Accounting Officer of the Company. There are also no family relationships between Ms. Ryu and any director or executive officer of the Company and Ms. Ryu has no direct or indirect interest in any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Kirstin Anderson, the Company’s former Corporate Controller and Principal Accounting Officer, has advanced to Senior Director of Finance, and will be focused on supporting the commercial launch of Vicineum TM .
Appointment of Elly Ryu as Principal Accounting Officer
Effective on April 22, 2021, Sesen Bio, Inc. (the “Company”) appointed Elly Ryu as the Company’s Corporate Controller and Principal Accounting Officer. No new compensatory arrangements will be entered into with Ms. Ryu in connection with her appointment as the Company’s Corporate Controller and Principal Accounting Officer.
Ms. Ryu, age 40, has served as the Company’s Senior Director, Accounting since February 2021. Before joining the Company, Ms. Ryu served as the Corporate Controller of Fi Holdings, LLC from January 2020 to February 2021. Previously, Ms. Ryu served as the Director of Accounting and Finance at Acrotech Biopharma, LLC from March 2019 to November 2019. Prior to that, Ms. Ryu served as the Director of Accounting and Finance at Spectrum Pharmaceuticals, Inc. from July 2017 to March 2019, Commercial Controller from January 2014 to June 2017, Assistant Controller from July 2010 to January 2014, and Senior Manager, Accounting and Finance from September 2009 to June 2010. Ms. Ryu holds a Masters in Business Administration from University of California, Irvine and a B.S. in Economics and Business Administration from the Sogang University, Seoul, South Korea.
There are no arrangements or understandings between Ms. Ryu and any other persons pursuant to which Ms. Ryu was appointed as the Corporate Controller and Principal Accounting Officer of the Company. There are also no family relationships between Ms. Ryu and any director or executive officer of the Company and Ms. Ryu has no direct or indirect interest in any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Kirstin Anderson, the Company’s former Corporate Controller and Principal Accounting Officer, has advanced to Senior Director of Finance, and will be focused on supporting the commercial launch of Vicineum TM .